Defence Therapeutics: Making a Global Impact
Defence Therapeutics is a Canadian Biotech company developing next generation bio-pharmaceutical innovations for various immuno-oncology (IO) and infectious diseases (ID) indications.
Stocks to Invest in: Healthcare
Defence Therapeutics is a Canadian Biotech company developing next generation biopharmaceutical innovations for various immuno-oncology (IO) and infectious diseases (ID) indications.
The company is located in Quebec, and their leadership team brings extensive eperience in the capital markets, finance, biochemistry, pharmacology, biotech, immunology.
Their platform is known as ACCUM, which is suitable to enhance the delivery of proteins, RNA and DNA.
Accum is overcoming problematic cell recycling and rejection patterns, ACCUM™ is the first solution to enable ADCs to control intracellular delivery of chemotherapeutic drugs, resulting in superior pre-clinical anti-tumor activity.
For more information on Defence Therapeutics Inc. (CSE: DTC, OTC: DTCFF) please click the request investor info button.
Latest Articles
.png)
Hot Companies
You might also like
%20(1).png)
Harvest ETFs: Expanding Income Opportunities with New High-Income Shares - HHIS
Harvest ETFs introduces five new high-income single-stock ETFs, offering investors exposure to leading companies like MicroStrategy, Coinbase, Tesla, Meta, and Palantir—all with the benefit of consistent monthly income.
